OABI
Price
$2.23
Change
-$0.08 (-3.46%)
Updated
Apr 3 closing price
Capitalization
272.36M
VCYT
Price
$27.97
Change
-$0.50 (-1.76%)
Updated
Apr 4, 11:37 AM (EDT)
Capitalization
1.66B
39 days until earnings call
Ad is loading...

OABI vs VCYT

Header iconOABI vs VCYT Comparison
Open Charts OABI vs VCYTBanner chart's image
OmniAb
Price$2.23
Change-$0.08 (-3.46%)
Volume$456K
Capitalization272.36M
Veracyte
Price$27.97
Change-$0.50 (-1.76%)
Volume$3.57K
Capitalization1.66B
OABI vs VCYT Comparison Chart
Loading...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OABI vs. VCYT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OABI is a StrongBuy and VCYT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (OABI: $2.23 vs. VCYT: $28.47)
Brand notoriety: OABI and VCYT are both not notable
OABI represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: OABI: 69% vs. VCYT: 92%
Market capitalization -- OABI: $272.36M vs. VCYT: $1.66B
OABI [@Biotechnology] is valued at $272.36M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OABI’s FA Score shows that 1 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • OABI’s FA Score: 1 green, 4 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, OABI is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OABI’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • OABI’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than OABI.

Price Growth

OABI (@Biotechnology) experienced а -9.72% price change this week, while VCYT (@Medical Specialties) price change was -8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.88%. For the same industry, the average monthly price growth was -2.40%, and the average quarterly price growth was -1.71%.

Reported Earning Dates

OABI is expected to report earnings on May 11, 2023.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-5.88% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than OABI($272M). VCYT YTD gains are higher at: -28.106 vs. OABI (-37.006). VCYT has higher annual earnings (EBITDA): -49.41M vs. OABI (-58.92M). VCYT has more cash in the bank: 216M vs. OABI (59.4M). VCYT has less debt than OABI: VCYT (12.6M) vs OABI (23.8M). VCYT has higher revenues than OABI: VCYT (361M) vs OABI (20.4M).
OABIVCYTOABI / VCYT
Capitalization272M1.66B16%
EBITDA-58.92M-49.41M119%
Gain YTD-37.006-28.106132%
P/E RatioN/AN/A-
Revenue20.4M361M6%
Total Cash59.4M216M28%
Total Debt23.8M12.6M189%
FUNDAMENTALS RATINGS
VCYT: Fundamental Ratings
VCYT
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OABIVCYT
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 5 days ago
55%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
66%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMORX34.86N/A
N/A
Patient Opportunity R
RYRRX49.25N/A
N/A
Rydex Russell 2000 A
VYSVX19.18N/A
N/A
Vericimetry US Small Cap Value
MNBRX19.40N/A
N/A
Manning & Napier Pro-Blend Extnd Term R
BBTLX14.21N/A
N/A
Bridge Builder Tax Managed Large Cap

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with TECH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
-3.25%
TECH - OABI
40%
Loosely correlated
-6.03%
ALEC - OABI
39%
Loosely correlated
-7.63%
NTLA - OABI
37%
Loosely correlated
-5.62%
AVIR - OABI
37%
Loosely correlated
+0.69%
VCYT - OABI
37%
Loosely correlated
-5.51%
More